Novartis Pharmaceuticals Australia Pty Ltd has advised HPS Pharmacies that EXFORGE HCT (amlodipine/ valsartan/hydrochlorothiazide) 10/320/25 mg tablets, Aust R 158168 is currently experiencing supply challenges and is expected to become temporarily unavailable.
HPS Pharmacies have obtained and consolidated remaining supplies to limit the effects of any shortage.
EXFORGE HCT offers the convenience of combining three single components used to treat hypertension. In the event that your HPS Pharmacies pharmacy has insufficient stock for your patient needs, we can offer advice on the selection of alternative doses of EXFORGE or other products which will achieve equivalent therapy.
No other dosage presentations of EXFORGE HCT tablets are affected by this notice.
Please retain this notice in a prominent position, including other related business units, until supplies return to normal. Should you require further information regarding this matter, please do not hesitate to contact your pharmacist at HPS Pharmacies or Novartis Customer Service on 1800 064 713.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.